Summary:
The primary goal of this study is to evaluate the safety and effectiveness of injections of the testosterone, undecanoate, in subjects with low testosterone hormone.
Qualified Participants Must:
• Be male with primary or secondary hypogonadism at least 18 years of age
•
Be lacking normal levels of Testosterone hormone (hypogonadal)
•
Be receiving endocrine replacement hormones, antihypertensives, lipid lowering agents, antidepressants or anxiolytic medications, the dose must be stable for at least 28 days
Qualified Participants May Receive:
Participants in the study will receive study related physical exams & blood tests, study medications and compensation for time and travel.